Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-11
DOI
10.1038/srep08374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNAs in Heart Failure
- (2014) Yonathan F. Melman et al. Circulation-Heart Failure
- Chronic Treatment With Qiliqiangxin Ameliorates Aortic Endothelial Cell Dysfunction in Diabetic Rats
- (2014) Fei Chen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
- (2014) Ignacio M. Seropian et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular remodelling in coronary artery disease and heart failure
- (2014) Gerd Heusch et al. LANCET
- Genetic and Pharmacological Inhibition of Rheb1-mTORC1 Signaling Exerts Cardioprotection against Adverse Cardiac Remodeling in Mice
- (2013) Xiangqi Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction
- (2013) Daniel Sürder et al. CIRCULATION
- Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function
- (2013) Jaco H. Houtgraaf et al. CIRCULATION RESEARCH
- MicroRNA-150
- (2013) Yvan Devaux et al. Circulation-Cardiovascular Genetics
- Peroxisome Proliferator–Activated Receptor-γ Activation Prevents Sepsis-Related Cardiac Dysfunction and Mortality In Mice
- (2013) Konstantinos Drosatos et al. Circulation-Heart Failure
- Adverse left ventricular remodelling after acute myocardial infarction: is there a simple treatment that really works?
- (2013) J. B. Muhlestein EUROPEAN HEART JOURNAL
- Cardiotonic Modulation in Heart Failure
- (2013) W. H. Wilson Tang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure
- (2013) Xinli Li et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience
- (2013) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
- (2013) Lichan Tao et al. Frontiers in Genetics
- The Convergence of Ancient Chinese Medicine With Modern Therapeutics to Prevent Cardiac Fibrosis
- (2012) Joseph S. Janicki et al. AMERICAN JOURNAL OF HYPERTENSION
- Novel therapeutic approaches to post-infarction remodelling
- (2012) D. Fraccarollo et al. CARDIOVASCULAR RESEARCH
- Pathological Role of Serum- and Glucocorticoid-Regulated Kinase 1 in Adverse Ventricular Remodeling
- (2012) Saumya Das et al. CIRCULATION
- PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
- (2012) Janice V. Huang et al. JOURNAL OF LIPID RESEARCH
- Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction
- (2012) Toyoharu Oba et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Qiliqiangxin Improves Cardiac Function in Spontaneously Hypertensive Rats Through the Inhibition of Cardiac Chymase
- (2011) W. Liu et al. AMERICAN JOURNAL OF HYPERTENSION
- Myocardial Remodeling: Cellular and Extracellular Events and Targets
- (2011) Jennifer A. Dixon et al. Annual Review of Physiology
- Regulatory T cells ameliorate cardiac remodeling after myocardial infarction
- (2011) Ting-Ting Tang et al. BASIC RESEARCH IN CARDIOLOGY
- PPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy
- (2011) Alex Morrison et al. BIOCHEMICAL PHARMACOLOGY
- Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice
- (2011) Yunzeng Zou et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction
- (2011) Gemma Vilahur et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Left Ventricular Remodeling in Heart Failure
- (2011) Marvin A. Konstam et al. JACC-Cardiovascular Imaging
- Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation
- (2009) Linda Slanec Higgins et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction
- (2009) Hong Xiao et al. CELLULAR IMMUNOLOGY
- The PPAR trio: Regulators of myocardial energy metabolism in health and disease
- (2008) Jose A. Madrazo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- PPAR-γin the Cardiovascular System
- (2007) Sheng Zhong Duan et al. PPAR Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More